Cardiology Online - International Academy of Cardiology
 
»search site
The International Academy of Cardiology is dedicated to the advancement of global research in cardiovascular medicine through the support of scientific meetings and publications.
   Home Page
   Congresses
   Journals
   Organizations
   Institutions
   Books
   Research
   Guidelines
   Discussion Groups
   Webcourses
   Websites
   Job Opportunities
   Contact Us

Connect with us

twitter

fb

instagram

youtube

24th World Congress on Heart Disease

 

 

 

 


IAC 2020

  IAC MEETINGS

IAC

International Academy of Cardiology
Annual Scientific Sessions 2022
24th World Congress on Heart Disease


boston Boston, MA, USA
July 2022
 

CME Meeting

Preliminary List of Scientific Presentations is online.

 


CI2020

31st Annual Cardiovascular Interventions - a live online complimentary symposium, taking place November 10-13th, 2020.

Course Director: Paul S. Teirstein, MD
Scripps Course Co-Directors: Matthew J. Price, MD; Richard A. Schatz, MD; Curtiss T. Stinis, MD

We hope you will join them next week for the live online Scripps 31st Annual Cardiovascular Interventions symposium, which will take place November 10-13th! This will be an exciting and completely live online experience that will include approximately 20 complex live cases, lectures and panels of experts from across the country, and sponsored satellite sessions on the latest state-of-the-art treatments and technologies.

This year, registration is completely complimentary for all participants and CME/CE will be provided for the live cases and lectures in the main symposium! Visit www.cvinterventions.com today to register, view the current agenda, and the detailed CME and CE information.

 
   
COVID-19 WEBINAR


“THE FIGHT AGAINST COVID-19 INFECTION"

Webinar
Stay on top of the rapidly growing body of scientific knowledge. Watch a recording from a live Webinar held on 4/29/2020, "The Fight Against COVID-19 Infection".

This educational session of the Preventative and Consultative (P&C) Heart Center of Excellence (COE), Smidt Heart Institute, Cedars Sinai Medical Center, was chaired by Asher Kimchi, M.D., and Daniel S. Berman, M.D., Medical Directors of the P&C Heart COE, Smidt Heart Institute.

PROGRAM:
“Covid-19 and the Heart”
Eduardo Marban, MD, PhD
Executive Director, Smidt Heart Institute

“Interleukin-6 inhibitors for Treatment of Cytokine Storm in COVID-19 Patients”
Stanley Jordan, MD
Director, Division of Nephrology and Kidney Transplant Program

“Antiviral Therapy for Patients with COVID-19 Infection”
Victor Tapson, MD
Co-Director, Pulmonary Hypertension Program

“Cardiosphere-Derived Cells (CDCs) in Severe COVID-19”
Siddharth Singh, MD
Assistant Director, Echo Fellowship Training Program, Smidt Heart Institute

“Immune Therapies for Covid-19”
Noah M. Merin, MD, PhD
Division of Hematology/Oncology

To access the video, click here.
Then, click on "Content & Tests" and "Launch Video."

 

MEETINGS AFFILIATED WITH THE IAC


To see more information on Previous Meetings Under the Auspices of the International Academy of Cardiology, click here.

 


 
 PREVIOUS MEETINGS OF THE IAC
 
   
Video from the 16th World Congress on Heart Disease

line    
 


bostonInternational Academy of Cardiology
Annual Scientific Sessions 2018
23rd World Congress on Heart Disease


The Westin Copley Place
Boston, MA, USA
July 27 - 29, 2018

CME Meeting
Photo Gallery

Presented abstracts have been published in a special online supplement issue of the journal CARDIOLOGY published by S. Karger AG, Basel, Switzerland.

line


vancouverInternational Academy of Cardiology
Annual Scientific Sessions 2017
22nd World Congress on Heart Disease


The Hyatt Regency Vancouver
Vancouver, BC, Canada
July 14 - 16, 2017

CME Meeting
Photo Gallery


Presented abstracts have been published in a special online supplement issue of the journal CARDIOLOGY published by S. Karger AG, Basel, Switzerland.

line

bostonInternational Academy of Cardiology
Annual Scientific Sessions 2016
21st World Congress on Heart Disease

The Westin Copley Place
Boston, MA, USA
July 30 - August 1, 2016

CME Meeting
Photo Gallery

vancouverInternational Academy of Cardiology
Annual Scientific Sessions 2015
20th World Congress on Heart Disease

Hyatt Regency Vancouver
Vancouver, BC, Canada
July 25-27, 2015


CME Meeting
Photo Gallery

boston International Academy of Cardiology
Annual Scientific Sessions 2014
19th World Congress on Heart Disease

Hyatt Regency, Boston, MA, USA
July 25-28, 2014

CME Meeting
Photo Gallery

torontoInternational Academy of Cardiology
18th WORLD CONGRESS ON HEART DISEASE
Annual Scientific Sessions 2013

July 26-29, 2013
Hyatt Regency, Vancouver, BC, Canada

CME Meeting
Photo Gallery


 


Photos from the 18th World Congress on Heart Disease (click here to see more photos)




To see more information on Previous IAC Meetings, click here.

 


 

  CARDIOLOGY ONLINE NEWS

Invited Speaker Presentations at the IAC Annual Scientific Sessions 2017, 22nd World Congress on Heart Disease, Boston, MA, USA
(click on the photo to view the video)


 
22nd WORLD CONGRESS ON HEART DISEASE

VASCULOPROTECTIVE ROLE OF NATRIURETIC PEPTIDE RECEPTOR C
Anand Srivastava
Madhu B. Anand-Srivastava, Ph.D., University of Montreal, Montreal, Quebec, Canada

VSMC from spontaneously hypertensive rats (SHR) exhibit enhanced proliferation and hypertrophy. We earlier showed that small peptide fragments of cytoplasmic domain of natriuretic receptor-C (NPR-C) attenuate vasoactive peptide-induced hyperproliferation and hypertrophy of VSMC, the key players of vascular remodeling. MORE»

REVASCULARIZATON IN PATIENTS WITH DIABETES MELLITUS: OPTIMAL APPROACH IN 2017
Barsness
Gregory W. Barsness, M.D., Mayo Clinic, Rochester, MN, USA

Background: Diabetes mellitus is a growing worldwide problem, affecting 28 million patients in the US, with another 80 million at risk due to obesity and related disorders. Diabetes mellitus is associated with significant health and social costs, with an estimated annual economic toll of $322 billion dollars in the US. MORE»

 

   

 

  CARDIOLOGY ONLINE NEWS

The Cardiology Online Journal
 Editor: Asher Kimchi, MD

Distinguished Cardiologists and Scientists Honored with 2018 International Academy of Cardiology Awards at the 23rd World Congress on Heart Disease, Boston, MA, USA

2017 AwardsDr. Asher Kimchi, Founder and Chairman of the International Academy of Cardiology (IAC) announced the winning recipients of the 2018 IAC Awards at the 23rd World Congress on Heart Disease held in Boston, MA, USA. In addition to the IAC awards, the committee also named four faculty to receive the Distinguished Fellowship Awards.

Asher Kimchi Dr. Asher Kimchi, together with Chairman Dr. Dr. John A. Elefteriades, headed a committee comprised of 222 of the world's leading cardiologists and scientists that reviewed a prestigious list of nominees and voted for their top choice.

The following awards for 2018 were presented at the Opening Ceremony of the International Academy of Cardiology Annual Scientific Sessions 2018, 23rd World Congress on Heart Disease, to honor the memory of distinguished colleagues, all former members of the faculty of previous International Academy of Cardiology meetings who made major contributions to Medicine and Cardiology: MORE»

Dr. Deepak Bhatt to Deliver Opening Lecture at International Academy of Cardiology, Annual Scientific Sessions 2018, 23rd World Congress on Heart Disease

Deepak L BhatDeepak L. Bhatt MD, MPH, Executive Director of Interventional Cardiovascular Programs at Brigham and Women’s Hospital Heart & Vascular Center and Professor of Medicine at Harvard Medical School, Boston, MA, USA, delivered the Twelfth H.J.C. Swan Memorial Lecture at the Opening Ceremony of the International Academy of Cardiology, Annual Scientific Sessions 2018, 23rd World Congress on Heart Disease, that was held in Boston, MA, USA, from Friday, July 27 through Sunday, July 29, 2018.

Dr. Bhatt presented on the topic of “Evolving Landscape of Antithrombotic Therapy for Atherosclerosis”. Aspirin remains the foundation of antiplatelet therapy. Trials soon to report will clarify its role in primary prevention. The role of aspirin in secondary prevention seems quite secure, though recent data have raised concerns about whether the enteric coating might impede its absorption and antiplatelet effects.
MORE»

Distinguished Cardiologists and Scientists Honored with 2017 International Academy of Cardiology Awards at the 22nd World Congress on Heart Disease, Vancouver, BC, Canada

2017 AwardsDr. Asher Kimchi, Founder and Chairman of the International Academy of Cardiology (IAC) announced the winning recipients of the 2017 IAC Awards at the 22nd World Congress on Heart Disease held in Vancouver, BC, Canada. In addition to the IAC awards, the committee also named four faculty to receive the Distinguished Fellowship Awards.

Dr. Asher Kimchi, together with Co-Chairmen Dr. Jeffrey S. Borer and Dr. John A. Elefteriades, headed a committee comprised of 191 of the world's leading cardiologists and scientists that reviewed a prestigious list of nominees and voted for their top choice.

The following awards for 2017 were presented at the Opening Ceremony of the International Academy of Cardiology Annual Scientific Sessions 2017, 22nd World Congress on Heart Disease, to honor the memory of distinguished colleagues, all former members of the faculty of previous International Academy of Cardiology meetings who made major contributions to Medicine and Cardiology: MORE»


Dr. Anne B. Curtis Delivered Opening Lecture at International Academy of Cardiology, Annual Scientific Sessions 2017, 22nd World Congress on Heart Disease

Anne CurtisAnne B. Curtis, M.D., SUNY Distinguished Professor and Charles and Mary Bauer Professor and Chair of the Department of Medicine at the University at Buffalo, New York, USA, delivered the eleventh H.J.C. Swan Memorial Lecture at the Opening Ceremony of the International Academy of Cardiology, Annual Scientific Sessions 2017, 22nd World Congress on Heart Disease, that was held in Vancouver, BC, Canada, from Friday, July 14 through Sunday, July 16, 2017.

Dr. Curtis presented on the topic of “Improvement in Quality of Care for Atrial Fibrillation in Get with the Guidelines – Atrial Fibrillation (GWTG-AFIB)”.
MORE»

Dr. Eugene Braunwald Delivered the 10th HJC Swan Memorial Lecture at the Opening Ceremony of the International Academy of Cardiology, Annual Scientific Sessions 2016, 21st World Congress on Heart Disease

Eugene BraunwaldEugene Braunwald, M.D., Distinguished Hersey Professor of Medicine at Harvard Medical School, and founding Chairman of the TIMI Study Group at the Brigham and Women’s Hospital, Boston, Massachusetts, USA, delivered the tenth H.J.C. Swan Memorial Lecture at the Opening Ceremony of the International Academy of Cardiology, Annual Scientific Sessions 2016, 21st World Congress on Heart Disease, that was held in Boston, MA, USA, from Saturday, July 30 through Monday, August 1, 2016.

Dr. Braunwald presented on the topic of “The War on Heart Failure”.
MORE»


Click here to view Cardiology Online News articles on Opening Lectures.

Click here to view more Cardiology Online News articles on Opening Ceremony of the IAC Annual Scientific Sessions and presentation of the IAC Awards.

Click here to view Invited Speaker Presentation Videos from Previous Meetings

Click here to see Invited Speaker Presentations from the International Academy of Cardiology
Annual Scientific Sessions 2018
23rd World Congress on Heart Disease

Click here to see Invited Speaker Presentations from the International Academy of Cardiology
Annual Scientific Sessions 2017
22nd World Congress on Heart Disease

 

Invited Speaker Presentations at the IAC Annual Scientific Sessions 2016, 21st World Congress on Heart Disease, Boston, MA, USA
(click on the photo to view the video)
 



 
21st WORLD CONGRESS ON HEART DISEASE

THE PRESENT AND FUTURE OF THE TOTAL ARTIFICIAL HEART
Arabia
Francisco Arabia, M.D., Cedars-Sinai Medical Center, Los Angeles, CA, USA

We aim to better understand the pt population with biventricular failure receiving TAH as a BTT, determine outcomes in 3 eras, effect of implanting ctr on outcomes, and adverse events related to this therapy. MORE»
 

2016 UPDATE ON TREATMENT OF HYPERTENSION
Aronow
Wilbert S. Aronow, M.D., Westchester Medical Center/New York Medical College, Valhalla, NY, USA

Numerous guidelines from 2011 through 2015 except for JNC 8 recommended that the blood pressure (BP) goal should be <140/90 mm Hg in persons younger than 80 years and <150 mm Hg in persons 80 years and older. JNC 8 recommended that the BP goal should be <150/90 mm Hg in persons 60 years and older without diabetes or chronic kidney disease. MORE»

 

DELIRIUM IN THE INTENSIVE CARE UNIT: MORE THAN A NUISANCE
Barness
Gregory W. Barsness, M.D., Mayo Clinic, Rochester, MN, USA

Regardless of the underlying condition and comorbidities, along with pain and agitation, delirium is a common condition with major impact on the care and outcome of patients requiring intensive care unit (ICU) hospitalization. MORE»

 

ACELLULAR BIOLOGICS FOR CARDIAC REGENERATION
Behfar
Atta Behfar, Ph.D., Mayo Clinic, Rochester, MN, USA

The global drive to generate new curative therapies is fueled by a growing unmet perpetuated by the heart failure pandemic. Regenerative trials in cardiovascular disease have focused on the use of cell-based therapy in acute myocardial injury, in order to halt progression towards heart failure, or in congestive heart failure, to regenerate a deteriorating myocardium. MORE»

PET AND CT ASSESSMENT OF CORONARY FLOW PHYSIOLOGY
Berman
Daniel S. Berman, M.D., Cedars-Sinai, Los Angeles, California USA

Assessment of fractional flow reserve (FFR) and coronary flow reserve by invasive coronary angiography provide physiologic assessments that complement the anatomic assessment of coronary stenosis for guiding patient management of patients with coronary artery disease. MORE»

 

CONTROVERSIES IN ANTIPLATELET AND ANTICOAGULANT THERAPY
Bhatt
Deepak L. Bhatt, M.D., Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA

Antiplatelet therapy is critical for patients with acute coronary syndromes, those undergoing coronary stenting, and especially for patients with both indications. Aspirin continues to be the backbone of antiplatelet strategies in cardiovascular secondary prevention. MORE»

PLAQUE LYMPHANGIOGENESIS: TO DRAIN OR NOT TO DRAIN
Biessen
Erik A. L. Biessen, Ph.D., Maastricht University, Maastricht, Netherlands

Vulnerable plaques are hallmarked by more pronounced inflammation and neoangiogenesis. Although angiogenesis and lymphangiogenesis are driven by partly overlapping cues, and especially under inflammatory conditions go hand in hand, plaque lymphangiogenesis only in one single earlier report been linked to plaque stability. MORE»

TICAGRELOR AND STATIN HAVE SYNERGISTIC EFFECTS ON MYOCARDIAL PROTECTION AGAINSY ISCHEMIA-REPERFUSION INJURY
Birnbaum
Yochai Birnbaum, M.D., Baylor College of Medicine, Houston, TX, USA

In addition to P2Y12 receptor antagonism, ticagrelor (TIC) inhibits the equilibrative- nucleoside-transporter-1 and thereby, adenosine cell re-uptake. Prior data show that TIC limits infarct size in non-diabetic rats and that the effect is adenosine dependent. MORE»

PREVENTION OF SUDDEN CARDIAC DEATH: CHALLENGES AND OPPORTUNITIES
Cain
Michael Cain, M.D., University at Buffalo, Buffalo, NY, USA

Strategies for prevention of sudden cardiac death in the setting of coronary artery disease rely on implantable cardiac defibrillators (ICD) in a subset of patients with left ventricular ejection fractions <35%. Many ICDs are implanted needlessly. MORE»


EXERCISE RELATED HYPERTENSION (ERH) MAY NOT BE A BENIGN PHENOMENON
Charuzi
Yzhar Charuzi, M.D., Cedars Sinai Medical Center, LA, USA

Blood Pressure (BP) increases with exercise. However a Systolic BP reaching or exceeding 200mm Hg is considered pathological. We recently observed a 78 years old male who, while walking uphill suddenly noticed loss of speech. MORE»

PREVENTION AND INTERFERENCE OF ATHEROSCLEROTIC HEART DISEASE IN MULTIPLE ANIMAL MODELS
Chatterjee
Subroto Chatterjee, Ph.D., Johns Hopkins University, Baltimore, MD, USA

We previously observed that the level of cholesterol and glycosphingolipids (GSL) rise and fall in tandem upon plasma exchange therapy in patients with LDL receptor negative homozygous familail hypercholesterolemia. MORE»

BIOMARKERS OF THE FUTURE: METABOLOMIC PREDICTORS OF CARDIOMETABOLIC DISEASE
Cheng
Susan Cheng, M.D., Brigham and Women's Hospital, Boston, MA, USA

By providing information on the diversity of small molecule metabolites in biological systems, current era metabolomics now offer the potential to comprehensively integrate data on both the intrinsic and extrinsic exposures that contribute to complex diseases such as cardiovascular disease. MORE»

RISK STRATIFICATION AND THERAPY OF ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY
Corrado
Domenico Corrado, M.D., Ph.D., University of Padova, Italy

Arrhythmogenic Right Ventricular Cardiomyopathy is a genetically determined cardiomyopathy which predisposes to life-threatening ventricular arrhythmias and arrhythmic cardiac arrest. The main goal of clinical management is prevention of sudden cardiac death. MORE»

IMPROVEMENT IN CLINICAL OUTCOMES WITH BIVENTRICULAR VERSUS RIGHT VENTRICULAR PACING IN THE BLOCK HF STUDY
Curtis
Anne B. Curtis, M.D., University of Buffalo, Buffalo, NY, USA

Sustained right ventricular (RV) apical pacing may lead to deterioration in ventricular function and an increased risk of heart failure, especially in patients with pre-existing systolic dysfunction. MORE»

SHORT AND LONG NON-CODING RNAs AS BIOMARKERS OF ACUTE CARDIAC CONDITIONS
Devaux
Yvan Devaux, Ph.D., Luxembourg Institute of Health, Luxembourg

The first draft of the human genome was published in 2001. However, it is only 10 years later that the ENCODE Int'l Consortium revealed that, while more than 80% of the human genome is transcribed into RNAs, only less than 2% of these RNAs are subsequently translated into proteins. MORE»


PATHOGENESIS AND THERAPY OF DIABETIC CARDIOMYOPATHY
Dhalla
Naranjan S. Dhalla, Ph.D., M.D. (Hon.), St. Boniface Hospital Albrechtsen Research Centre, University of Manitoba, Winnipeg, MB, Canada

Chronic diabetes is known to be associated with the development of cardiomyopathy, metabolic derangement and cardiac dysfunction. Extensive studies in our laboratory have revealed that cardiac dysfunction due to chronic diabetes is associated with marked alterations in subcellular organelles such as myofibrils, sarcoplasmic reticulum and sarcolemma. MORE»

CARDIAC IMAGING FOR EVALUATION OF CORONARY ARTERY DISEASE IN PATIENTS WITH HYPERTENSION
Elhendy
Abdou Elhendy, M.D., Ph.D., Marshfield Clinic, Marshfield, WI, USA

Hypertension is a major risk factor for coronary artery disease (CAD) and related morbidity. Identification of an accurate non-invasive method for diagnosis of CAD is important to plan therapeutic and interventional management in order to improve outcome. MORE»

HIGH-SENSITIVITY ASSAY FOR CARDIAC TROPONIN: NOVEL TOOLS FOR RISK PREDICTION IN AMBULATORY PATIENTS
Everett
Brendan M. Everett, M.D., Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA

Assays for cardiac troponin have become increasingly sensitive, and are now able to detect very low concentrations of circulating cardiac troponin in a substantial proportion of stable patients who are not suspected of having myocardial infarction. MORE»

CpG DNA REGULATION OF COAGULATION: IMPLICATIONS FOR ACUTE CORONARY ARTERY DISEASE
Filep
Janos G. Filep, M.D., University of Montreal, Montreal, Quebec, Canada

Bacteraemia is associated with increased risk of acute coronary artery disease and stroke. Bacterial DNA and mitochondrial DNA, containing unmethylated CpG dinucleotide motifs are potent inducers of immune responses during infection MORE»


HYPERTENSION UPDATE: QUO VADIMUS?
Galis
Zorina S. Galis, Ph.D., Vascular Biology and Hypertension, National Heart Lung and Blood Institute, Bethesda, MD, USA

Hypertension continues to represent a formidable challenge to human health and to healthcare worldwide. Exciting new developments in clinical and fundamental hypertension research are poised to change how we understand and approach the clinical management of hypertension. MORE»

COMPUTED TOMOGRAPHY ANGIOGRAPHY VS. CORONARY ANGIOGRAPHY: A 3D VESSEL FEATURE COMPARISON AND VALIDATION
Garcia
Joel Garcia, M.D., Orlando Health, Orlando, FL, USA

Differences in vessel features between computed tomography angiograms (CTA) and coronary angiograms have not been rigorously studied, therefore we sought to validate CTA 3-dimensional (3D) vessel data against coronary angiography MORE»


ROLE OF ECHOCARDIOGRAPHY IN EPIDEMIOLOGIC STUDIES AND CLINICAL TRIALS: AN HISTORICAL PERSPECTIVE
Gardin
Julius M. Gardin, M.D., Hackensack University Medical Center, Rutgers New Jersey Medical School, NJ, USA

Non-invasive transthoracic echocardiography (TTE) for assessment of subclinical and clinical heart disease – initially, left ventricular (LV) mass, geometry and function – dates from the 1980’s. In parallel, TTE successfully demonstrated in hypertensive patients reduced LV mass and improved outcomes MORE»

THYROID HORMONE TREATMENT OF HEART FAILURE: IS THERE A THERAPEUTIC WINDOW?
Gerdes
A. Martin Gerdes, Ph.D., New York Institute of Technology – College of Osteopathic Medicine, Old Westbury, NY, USA

In 1950, a study showed that Thyroid Hormone (TH) treatment significantly reduced cardiovascular mortality and rates of myocardial infarction in three patient groups. Rather than extend these findings, subsequent poorly designed larger clinical studies using toxic doses of TH analogs MORE»

THE CENTRAL ROLE OF SMOOTH MUSCLE CELL MITOCHONDRIA IN THE PREVENTION OF ABDOMINAL AORTIC ANEURYSM BY LOW LEVEL LASER THERAPY
Gertz
S. David Gertz, M.D., Ph.D., The Hebrew University of Jerusalem and Hadassah University Hospital, Jerusalem, Israel

We showed, by high frequency ultrasound, that phototherapy with low-level laser, a non-thermal, near-infrared radiation, used widely for reduction of pain and acceleration of wound healing, prevents de novo formation and progression of pre-existing abdominal aortic aneurysm MORE»

UPDATE ON ASPIRIN IN THE PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE
Hennekens
Charles H. Hennekens, M.D., Dr.P.H., Florida Atlantic University, Boca Raton, FL, USA

In secondary prevention among a wide range of patients who have survived a prior occlusive vascular event, as well as during acute myocardial infarction and acute occlusive stroke the absolute reductions far exceed the absolute risks. In primary prevention, tbe balance is less clear. MORE»


IMPACT OF EXERCISE CAPACITY FOR RIGHT AND LEFT HEART FAILURE
Hirashiki
Akihiro Hirashiki, M.D., Nagoya University School of Medicine, Nagoya, Japan

Cardiopulmonary exercise testing is a diagnostic tool used to detect serial changes in exercise capacity, and it is of particular benefit for patients with chronic heart failure to assess peak oxygen uptake (peak VO2) and minute ventilation/carbon dioxide production (VE/VCO2) slope. MORE»

ATRIAL FUNCTIONAL MITRAL REGURGITATION: THE LEFT ATRIUM GETS ITS DUE RESPECT
Hoit
Brian D. Hoit, M.D., University Hospitals Case Medical Center, Case Western Reserve University. Cleveland, OH, USA

Moderate or greater mitral regurgitation (MR) is the most frequent valve disease in the United States. Competence of the mitral valve requires the temporally and spatially coordinated interaction of the mitral leaflets with the annulus, chordae tendinae, and papillary muscles; MORE»

INITIAL STAGES OF OBESITY ARE ASSOCIATED WITH INCREASED CARDIOVASCULAR ACTIVATION UNDER STRESS
Jezova
Daniella Jezova, M.D., Slovak Academy of Sciences, Bratislava, Slovakia

Stress and obesity are well known risk factors for cardiovascular diseases. The recognition of early markers of cardiovascular risk during the development of obesity is essential. The hypothesis tested was that under stress conditions subjects at initial stages of obesity MORE»

ATRIAL FUNCTIONAL MITRAL REGURGITATION: MACROPHAGE DEPOSITION OF CHOLESTEROL INTO THE EXTRACELLULAR MATRIX - A PATHWAY FOR REVERSE CHOLESTEROL TRANSPORT
Jin
Xueting Jin, M.D., National Institutes of Health, Bethesda, Maryland, USA

To investigate the potential for mobilization of extracellular cholesterol within atherosclerotic plaques. Background: Atherosclerotic plaques develop as a result of an imbalance between cholesterol accumulation and cholesterol removal. MORE»

THE BENEFITS AND RISKS OF LEFT VENTRICULAR ASSIST DEVICE IMPLANTATION; WHERE IS THE POINT OF CLINICAL EQUIPOISE?
Johnson
Maryl R. Johnson, M.D., University of Wisconsin, Madison, WI, USA

Left ventricular assist devices (LVADs) are used to treat patients with severe heart failure, both as a bridge to transplantation and as destination therapy. However, the best time to proceed with LVAD implantation remains to be determined. MORE»

AGING AND HEART FAILURE 2016. UPDATE
Jugdutt
Bodh I. Jugdutt, M.D., University of Alberta, Edmonton, Alberta, Canada

Concurrent worldwide increases in the aging population and prevalence of heart failure (HF) are accompanied by a parallel increase in the elderly (age = 65 years) with two leading causes of HF, hypertension and myocardial infarction. MORE»

TRANSITION TO STAGE D HEART FAILURE AMONG STABLE OUTPATIENTS WITH SYSTOLIC HEART FAILURE
Kalogeropoulos
Andreas P. Kalogeropoulos, M.D., Ph.D., Emory University, Atlanta, GA, USA

Incidence rates and risk factors for transition to Stage D heart failure (HF) among patients with stable, Stage C HF with reduced ejection fraction have not been described. Methods: We evaluated 3-year transition rates to clinically determined Stage D HF, after accounting for competing mortality, in 919 outpatients MORE»

TRANSULNAR INTERVENTIONS
Kaluski
Edo Kaluski, M.D., Guthrie Health System, PA, USA

The use of transradial access for diagnostic and therapeutic interventions has dramatically increased in the recent years and has become the preferred approach for coronary angiography and intervention. The ulnar artery is similar in diameter however is somewhat deeper MORE»

THE ROLE OF ECHOCARDIOGRAPHY IN THE MANAGEMENT OF PATIENTS UNDERGOING VENTRICULAR ASSIST DEVICE IMPLANTATION AND/OR TRANSPLANT SURGERY
Kato
Tomoko S. Kato, M.D., Ph.D. , Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan

Heart transplantation (HTx) is a curative treatment for patients with advanced heart failure; however, since transplant opportunity is severely limited due to donor shortage, left ventricular assist device has evolved into a standard therapy for patients awaiting HTx. MORE»

TREATING FLUID OVERLOAD WITH FLUID; ROLE OF PERITONEAL DIALYSIS IN MANAGEMENT OF HEART FAILURE
Kazory
Amir Kazory, M.D., University of Florida, Gainesville, Florida, USA

Heart failure (HF) remains the most common reason for hospital admission in older patients resulting in significant burden on healthcare expenditure. The currently available therapeutic modalities for HF do not seem yet to be producing optimal results. MORE»

THE USE OF POINT OF CARE ULTRASOUND TO GUIDE MANAGEMENT IN HEART FAILURE
Kedan
Ilan Kedan, M.D.
, Cedars Sinai Heart Institute, Beverly Hills, CA, USA

Point of Care ultrasound has long been used in the acute care and emergency setting for management of trauma patients. MORE»

EDUCATION AND MORTALITY: IS A COLLEGE DEGREE UNIVERSALLY PROTECTIVE?
Klatsky
Arthur L. Klatsky, M.D., Kaiser Permanente Division of Research, Oakland, CA, USA

To study risk of death in relation to educational attainment in 273,843 persons. Background: Low socio-economic status has been associated with increased incidence of many medical conditions and connected to racial and ethnic health disparities. MORE»

EFFECT OF ENDOTHELIAL CELL SENESCENCE ON THE HEAT SHOCK RESPONSE AND CELLULAR FUNCTION
Knowlton
Anne. A. Knowlton, M.D., Sacramento VA Medical Center, Mather, CA USA and University of California, Davis, CA, USA

Increasing evidence supports that replicative senescence, cessation of cell division, plays a role in the progression of the aging phenotype. With cellular senescence, cells undergo morphologic, physiologic and functional changes. MORE»

DOES CYSTATIN SN INFLUENCE ON CYSTATIN C LEVEL IN ISCHEMIA AND PREVIOUS MYOCARDIAL INFARCTION?
Korolenko
Tatiana A. Korolenko, Ph.D., Institute Physiol. Fund. Med., Novosibirsk, Russia

Objectives: To investigate whether patients with ischemic heart disease and previous myocardial infarction (MI) display altered serum cystatin C/cystatin SN ratio. MORE»

CURRENT STATUS OF INTRAVASCULAR IMAGING
Koshy
Santhosh K.G. Koshy, M.D., University of Tennessee Health Sciences Center, Memphis TN, USA

Diagnostic angiography has been the mainstay of confirmatory diagnosis of vascular atherosclerosis. Being a luminogram its ability to determine the presence and extent of atherosclerosis is limited by changes in the vessel wall that is adjacent to the atherosclerotic plaque. MORE»

ROLE OF CVD RISK ASSESSMENT IN COPD
Lee
Hwa Mu Lee, M.D., University of California, Irvine, Irvine, CA, USA

Chronic obstructive pulmonary disease is commonly associated with cardiovascular disease since they are both linked with shared factors such as age and smoking history; however, in clinical practice, these two diseases are treated separately. MORE»


DECIPHERING THE ROLE OF MITOPHAGY IN THE HEART DURING FASTING
Liang
Qiangrong Liang, M.D., Ph.D., New York Institute of Technology – College of Osteopathic Medicine, Old Westbury, NY, USA

Alternate-day fasting or starvation is beneficial to the heart, but the underlying mechanism remains speculative. Starvation activates general autophagy, which may contribute to the cardioprotective effect of fasting. MORE»

AVOIDING AND SOLVING COMPLICATIONS DURING PERCUTANEOUS CLOSURE OF ASD
Lorber
Avraham Lorber, M.D., Rambam Medical Campus, Haifa, Israel

We present 11 cases of percutaneous transcatheter occlusion of atrial septal defects in adults. These select cases represent an educational approach to special dilemmas, complications, and challenges MORE»

GLYCOSAMINOGLYCANS (GAGS) IN CARDIOVASCULAR DISEASE: SEARCHING FOR THE SWEET SPOT
Lucas
Alexandra R. Lucas, M.D., University of Florida, Gainesville, FL, USA

The endothelial glycocalyx alters immune reactions. Among other functions, glycosaminoglycans in the glycocalyx bind chemokines that attract immune cell invasion. MORE»

TRANSLATING VASCULAR BIOLOGY INTO CLINICAL CARE FOR CARDIOLOGY
Maiese
Kenneth Maiese, M.D., Rutgers University of Medicine & Dentistry of New Jersey

With the progressing aging of the world’s population, cardiovascular disease will continue to significantly impact millions of individuals throughout the globe. This disorder remains one of five leading causes of death that are cardiac disease, cancer, MORE»

A NANOMEDICAL APPROACH TO THE RESTORATION OF DYSFUNCTIONAL ENDOTHELIUM AND THE FUNCTION OF THE CARDIOVASCULAR SYSTEM
Malinski
Tadeusz Malinski, Ph.D., Ohio University, Athens, OH, USA

A dysfunctional endothelium is a common denominator in aging and several cardiovascular diseases: hypertension, diabetes, salt-induced hypertension and atherosclerosis. MORE»

 

CLINICAL GENETICS OF DILATED CARDIOMYOPATHY- TESTING WISELY
Marsh
James D. Marsh, M.D., University of Arkansas for Medical Sciences, Little Rock, AR, USA

Dilated cardiomyopathies (DCM) account for 10,000 deaths/year in the US; African-Americans have a 3-fold increased risk. There has been little solid information available on or the ability to make a precise genetic diagnosis in DCM. MORE»

WHAT HAPPENS TO THE BRAIN AFTER MYOCARDIAL INFARCTION?
Mehta
Jawahar L. Mehta, M.D., Ph.D. , University of Arkansas for Medical Sciences and VA Medical Center, Little Rock, AR, USA

It is assumed, but not proven, that acute myocardial infarction affects function of remote organs- such as kidneys and brain. We examined brain morphology in wild type (WT) mice subjected to left coronary artery (LCA) ligation. MORE»

OPTIONS FOR REMOTE PATIENT MONITORING IN THE LVAD POPULATION
Meyer
Dan M. Meyer, M.D., Methodist Health System, Dallas, Texas, USA

Multiple technologies are emerging that may have roles in remote patient monitoring in the LVAD population. These include smartphone applications and wearables, nanosensors, lab-on-a-chip platforms, and miniaturized systems. MORE»

SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS
Mora
Samia Mora, M.D.
, Brigham and Women's Hospital, Boston, MA, USA

Cardiovascular risk among individuals with manifest cardiovascular disease remains high and has been termed “residual risk”. Results from a meta-analysis of statin trials involving 90,056 individuals found that the rate of a major vascular event MORE»

 

UPDATE ON CONTRAST REMOVAL FROM CORONARY SINUS DURING CORONARY ANGIOGRAPHY OR INTERVENTION FOR PREVENTION OF CONTRAST INDUCED NEPHROPATHY
Movahed
Mohammad-Reza Movahed, M.D., Ph.D., CareMore, Tucson, Arizona, University of Arizona College of Medicine, USA

Contrast usage during coronary angiography or intervention in patients with renal disease is associated with substantial risk of contrast induced nephropathy that can lead to higher mortality, longer hospital stay and substantial cost. MORE»
 

CAN GDF-15 BE USED AS A BIOMARKER IN DILATED CARDIOMYOPATHY
Nair
Nandini Nair, M.D., Ph.D., Texas Tech HSC, Lubbock, TX, USA

Growth and Differentiation Factor-15 (GDF-15) has been found to play an important role in fibrosis, inflammation and ventricular remodeling. The role of GDF-15 in regulation of cardiac remodeling in idiopathic dilated cardiomyopathy is less well-defined. MORE»

INNOVATIVE P-WAVE DETECTION FOR DISCRIMINATION BETWEEN VENTRICULAR AND SUPRAVENTRICULAR TACHYCARDIA IN SINGLE-CHAMBER ICDS: IS THE P-WAVE INVISIBLE DURING TACHYCARDIA?
Paydak
Hakan Paydak, M.D. , UAMS, Little Rock, AR, USA

Differentiation between supraventricular tachycardia and ventricular tachycardia remains a substantial clinical challenge in patients with single-chamber implantable cardioverter-defibrillators due to absence of visible P waves. MORE»

 

LOW GRADIENT SEVERE AORTIC STENOSIS: ECHO FEATURES AND CLINICAL SIGNIFICANCE
Pellikka
Patricia A. Pellikka, M.D., Mayo Clinic, Rochester, MN, USA

Current practice guidelines define severe aortic stenosis (AS) as aortic valve (AV) area less than1 cm2 and mean AV gradient greater than 40 mmHg. Low gradient severe AS refers to the condition of mismatch between an AV area which suggests severe AS and mean gradient MORE»

VALVE PROSTHESIS-PATIENT MISMATCH (VP-PM): A LONG-TERM PERSPECTIVE
Rahimtoola
Shahbudin H. Rahimtoola, M.D., University of Southern California, Los Angeles, CA, USA

VP- PM was first described in 1978 by Rahimtoola. From that time to 2011, aortic VP-PM has received a great deal of attention but studies have come to varying conclusions especially with regard to its effect on mortality. MORE»

 

 

OSTEOGENIC DIFFERENTIATION IS A MECHANISM FOR BIOPROSTHETIC VALVE CALCIFICATION
Rajamannan
Nalini M. Rajamannan, M.D., Mayo Clinic, Rochester, MN, USA

Bioprosthetic heart valve calcification is the major cause of structural valve deterioration (SVD). The mechanism of valve degeneration is unknown. This study hypothesizes that bioprosthetic valve calcification is a stem cell mediated bone differentiation process. MORE»

THE HIGHLY DIFFICULT LIPOPROTEIN: CONTROVERSIES AND NEW DIRECTIONS
Rosenson
Robert S. Rosenson, Ph.D., Icahn School of Medicine at Mount Sinai, New York, NY, USA

Classical epidemiology has established the incremental contribution of the high density lipoprotein (HDL) cholesterol measure in the assessment of atherosclerotic cardiovascular disease risk; however, genetic epidemiology does not support a causal relationship between HDL cholesterol and future risk of myocardial infarction. MORE»

CXCR6/CXCL16 AXIS IS INVOLVED IN MONONUCLEAR CELL ADHESION INDUCED BY ANGIOTENSIN II, POTENTIAL IMPLICATION IN ABDOMINAL AORTIC ANEURYSM (AAA) FORMATION?
Sanz
Maria J. Sanz, Ph.D., Faculty of Medicine, University of Valencia, Valencia, Spain

Abdominal aortic aneurysm is a degenerative disease of the aorta that mainly affects elderly population over the age of 65. Nowadays the pathways involved in its onset and progression remain unknown and angiotensin-II has been widely implicated. MORE»

CARDIOVASCULAR EFFECTS OF CARFILZOMIB, A NEW PROTEASOME INHIBITOR, ON CORONARY ARTERY RESISTANCE, VASCULAR TONE AND VASCULAR REACTIVITY
Scarabelli
Tiziano M. Scarabelli, M.D., The University of Alabama at Birmingham, Birmingham, AL, USA

Carfilzomib is a proteasome inhibitor which was recently approved in the United States as a single agent for the treatment of patients with relapsed and refractory Multiple Myeloma. Chemically it is a tetrapeptide epoxyketone and an analog of epoxomicin. MORE»


COMPARISON OF EARLY HEMODYNAMIC PERFORMANCE OF STENTED PERICARDIAL AND PORCINE AORTIC VALVES
Sharma
Rakesh K. Sharma, M.D., University of Utah, Salt Lake City, UT, USA

Data comparing the hemodynamic performance of stented pericardial and porcine aortic valves are conflicting. We performed a systematic review and meta-analysis comparing the early hemodynamic parameters of stented pericardial and porcine valves in patients undergoing isolated aortic valve replacement. MORE»

ASTHMA AS A RISK FACTOR OF HUMAN AND EXPERIMENTAL ABDOMINAL AORTIC ANEURYSM
Shi
Guo-Ping Shi, SC.D., D.SC., Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA

Asthma and abdominal aortic aneurysms (AAA) both involve inflammation. It remains unknown whether these diseases interact. MORE»

THE CANCER ASSOCIATED FIBROBLAST AND THE HEART FAILURE ASSOCIATED FIBROBLAST- SIMILAR PHENOTYPE, SIMILAR PATHWAYS LEADING TO POTENTIALLY SIMILAR TREATMENT
Spinale
Francis G. Spinale, Ph.D., M.D., USC School of Medicine and WJB Dorn VA, Columbia, SC, USA

While morbidity, mortality, and health care costs associated with heart failure (HF) are increasing, advancements in early diagnosis and treatment strategies have not been forthcoming. Firstly, there is a need to differentiate HF phenotypes into different disease processes MORE»

RISK STRATIFICATION IN BRUGADA SYNDROME: ICD INDICATION IN PATIENTS WITHOUT HISTORY OF CARDIAC ARREST
Takagi
Masahiko Takagi, M.D., Ph.D., Osaka City Graduate School of Medicine, Osaka, Japan

Risk assessment in patients without previous documented VF or aborted sudden death (SCD) is not yet fully established. Indication for implantable cardioverter defibrillator in Brugada patients without documented VF or SCD is classified as Class II or III indication. MORE»

OPTIMUM TREATMENT OF ANGINA PECTORIS SHOULD TAKE INTO CONSIDERATION PATIENTS’ CIRCULATORY STATUS AND THE PRESENCE OF ASSOCIATED COMORBIDITIES IN THE YEAR 2016
Thadani
Udho Thadani, M.D., M.D., OU Medical Center and VA Medical Center, Oklahoma City, Oklahoma, USA

Currently many treatment options, including medicines, and revascularization procedures are available to treat patients with stable angina pectoris. All patients with angina pectoris due to underlying CAD should be treated with a low dose aspirin and a high dose, potent statin, if tolerated, MORE»

PREVENTION OF ACUTE MI BY AGGRESSIVE APPROACH TO TREAT UNSTABLE ANGINA
Ueda
Yasunori Ueda, M.D., Ph.D., Osaka National Hospital, Osaka, Japan

Although the incidence of in-hospital death from acute myocardial infarction (MI) is about 5%, about 40% of the patients who suffer acute MI die before hospitalization. MORE»


THE ROLE OF HEMODYNAMIC SUPPORT IN THE MANAGEMENT OF AMI WITH SHOCK
Vetrovec
George W. Vetrovec, M.D., VCU Medical Center Richmond, Virginia USA

Outcomes for Acute Myocardial Infarction have improved significantly with acute Percutaneous Coronary Intervention. However, the incidence of associated cardiogenic shock has increased and remains a major cause of death. MORE»

SEX DIFFERENCES IN THE CARDIOVASCULAR CONSEQUENCES OF DIABETES MELLITUS
Wenger
Nanette K. Wenger, M.D., Emory University School of Medicine, Atlanta, GA, USA

Cardiovascular disease is the leading cause of morbidity and mortality with type 2 diabetes mellitus, accounting for > 75% of hospitalizations and >5% of deaths. Women have a 3-fold excess of coronary heart disease risk compared to men MORE»

EFFICACY OF A CARDIOVASCULAR BEHAVIORAL INTERVENTION PROGRAM ON PROGRESSION OF ATHEROSCLEROSIS
Wong
Nathan D. Wong, Ph.D., University of California, Irvine, CA, USA

Limited data exist on the efficacy of multifactorial lifestyle programs on impacting the progression of atherosclerosis. We examined the efficacy of a lifestyle intervention program on progression of coronary artery calcium. MORE»

WHOLE HEART REGENERATION WITH HUMAN iPS CELL-DERIVED HEART PROGENITORS
Yang
Lei Yang, Ph.D., University of Pittsburgh, Pittsburgh, PA, USA

In US, about 50,000 people die each year due to the limited donor hearts for transplant. Thus the future treatment of heart disease requires the development of personalized therapeutic strategies, such as patient-specific cardiac tissues or whole bio-artificial hearts for transplantation. MORE»

 


 

 



   

INVITED SPEAKER PRESENTATIONS FROM PREVIOUS MEETINGS

 

Click here to see Invited Speaker Presentations from the International Academy of Cardiology
Annual Scientific Sessions 2018
23rd World Congress on Heart Disease

Click here to see Invited Speaker Presentations from the International Academy of Cardiology
Annual Scientific Sessions 2017
22nd World Congress on Heart Disease

Click here to see Invited Speaker Presentations from the International Academy of Cardiology
Annual Scientific Sessions 2016
21st World Congress on Heart Disease

Click here to see Invited Speaker Presentations from the International Academy of Cardiology
Annual Scientific Sessions 2015
20th World Congress on Heart Disease

Click here to see Invited Speaker Presentations from the International Academy of Cardiology
Annual Scientific Sessions 2014
19th World Congress on Heart Disease

Click here to see Invited Speaker Presentations from the International Academy of Cardiology
Annual Scientific Sessions 2013
18th World Congress on Heart Disease

Click here to see Invited Speaker Presentations from the International Academy of Cardiology
Annual Scientific Sessions 2012
17th World Congress on Heart Disease


 

 

Click here to see more articles from Cardiology Online News


 

 


©1998-2020 Cardiology Online, Inc. All rights reserved.
Cardiology Online is a registered trademark of Cardiology Online, Inc.
CardiologyOnline.com